Apogee Therapeutics, Inc.APGENASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-227.45M
↓ 86% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-122.45M
Historical baseline
PeriodValueYoY Change
2025$-227.45M-32.9%
2024$-171.17M-129.0%
2023$-74.76M-355.1%
2022$-16.43M-